Skip to main content

Randhawa Simrat's Form 4 filing

Dianthus Therapeutics, Inc. (DNTH) · filed Nov 14, 2025

Accession no.
0001992260-25-000008
Filed
Nov 14, 2025
Trade date
Nov 13-14, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 5 derivative transactions. Open-market sales total $7.38M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Randhawa SimratCIK 0001992260Officer (EVP, Head of R&D)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2025Common StockMOption exerciseAcquired+83,978$8.44+$708,774.3287,978Direct
Nov 13, 2025Common StockMOption exerciseAcquired+3,529$17.88+$63,098.5291,507Direct
Nov 13, 2025Common StockSSaleDisposed−26,166$35.80−$936,742.865,341Direct
Nov 13, 2025Common StockSSaleDisposed−42,765$37.04−$1,584,015.622,576Direct
Nov 13, 2025Common StockSSaleDisposed−18,576$37.72−$700,686.724,000Direct
Nov 14, 2025Common StockMOption exerciseAcquired+40,287$17.88+$720,331.5644,287Direct
Nov 14, 2025Common StockMOption exerciseAcquired+37,494$21.77+$816,244.3881,781Direct
Nov 14, 2025Common StockMOption exerciseAcquired+31,250$22.07+$689,687.5113,031Direct
Nov 14, 2025Common StockSSaleDisposed−109,031$38.14−$4,158,442.344,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 13, 2025Common StockMOption exerciseDisposed−83,978$0.00$011,996Direct
Nov 13, 2025Common StockMOption exerciseDisposed−3,529$0.00$0116,471Direct
Nov 14, 2025Common StockMOption exerciseDisposed−40,287$0.00$076,184Direct
Nov 14, 2025Common StockMOption exerciseDisposed−37,494$0.00$062,506Direct
Nov 14, 2025Common StockMOption exerciseDisposed−31,250$0.00$0118,750Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)